Drug combination and its use in the treatment of muscle loss

Details Drug combination and its use in the treatment of muscle loss Drug combination and its use in the treatment of muscle loss

A - Human Necessities

61

K

A61K 31/137 (2006.01) A61K 31/167 (2006.01) A61K 31/4704 (2006.01) A61K 31/57 (2006.01) A61K 31/704 (2006.01) A61P 9/00 (2006.01) A61P 11/00 (2006.01) A61P 31/18 (2006.01) A61P 35/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2721739

The present invention is a product comprising a.beta.2 agonist and a progestin, as a combined preparation for separate, simultaneous or sequential use in the treatment or prevention of muscle loss. The present invention is also a.beta.2 agonist selected from R,R-formoterol, indacaterol or ritodrine, for use in the treatment or prevention of muscle loss.

La présente invention concerne un produit comprenant un agoniste ß2 et un progestatif, comme préparation combinée pour une utilisation séparée, simultannée ou séquentielle dans le traitement ou la prévention de la perte musculaire. La présente invention concerne également un agoniste ß2 choisi parmi le R,R-formotérol, l'indacatérol ou la ritodrine, pour une utilisation dans le traitement ou la prévention de la perte musculaire.

Affiliated with

Also associated with

Rating

Drug combination and its use in the treatment of muscle loss does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug combination and its use in the treatment of muscle loss, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug combination and its use in the treatment of muscle loss will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1452641